PembrolizumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1837卷 / 1期

关键词：

D O I：

10.1007/s40278-021-89169-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：570 / 570

相关论文

共 50 条

[21] PembrolizumabHypophysitis with acute progression of pre-existing Rathke's cleft cyst: case report
Reactions Weekly, 2022, 1900 (1) : 271 - 271
[22] PembrolizumabHypophysitis
Reactions Weekly, 2023, 1984 (1) : 435 - 435
[23] PembrolizumabHypophysitis
Reactions Weekly, 2023, 1985 (1) : 422 - 422
[24] Ipilimumab/Nivolumab/PembrolizumabHypophysitis: 3 case reports
Reactions Weekly, 2024, 2037 (1) : 222 - 222
[25] PembrolizumabHypophysitis and adrenal insufficiency: 2 case reports
Reactions Weekly, 2017, 1661 (1) : 272 - 272
[26] Axitinib/pembrolizumabHypophysitis, pancreatitis and asthenia: 3 case reports
Reactions Weekly, 2023, 1958 (1) : 84 - 84
[27] Ipilimumab/pembrolizumabHypophysitis and various other toxicities: 15 case reports
Reactions Weekly, 2019, 1761 (1) : 213 - 213
[28] PembrolizumabHypophysitis, pancreatitis and pneumonia following off-label use: 3 case reports
Reactions Weekly, 2022, 1934 (1) : 360 - 360
[29] PembrolizumabHypophysitis and isolated ACTH deficiency
Reactions Weekly, 2023, 1985 (1) : 423 - 423
[30] UlixertinibFirst case report of retinopathy: case report
Reactions Weekly, 2020, 1829 (1) : 350 - 350

← 1 2 3 4 5 →